Jagdev Singh Sekhon - Concepedia

Author

Jagdev Singh Sekhon

Also Known As

J S Sekhon, J.S. Sekhon, Jagdev S Sekhon, Jagdev S. Sekhon, Jagdev Sekhon, Jagdev Singh Sekhon

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Jagdev Singh Sekhon is an author at Dayanand Medical College & Hospital specializing in drug resistance, antimicrobial resistance, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	689
2	Pharmacology	1	1	689
3	Drug Resistance	1	1	689
4	Antifungal Agents	1	1	689
5	Antimicrobial Resistance	1	1	689

Jagdev Singh Sekhon

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha, The Lancet Invasive CandidosisAntifungal AgentAntifungal AgentsMedicinePhase Iii	2007	689
Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz, Journal of Clinical Oncology	2008	418
A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer Dinesh Chandra Doval, Jagdev Singh Sekhon, Sunil K. Gupta, British Journal of Cancer	2004	136
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy Purvish M. Parikh, Ashok K. Vaid, Suresh H. Advani, Journal of Clinical Oncology	2011	75
A multicenter phase II randomized study of Cremophor‐free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline Anantbhushan Ranade, P. P. Bapsy, Shona Nag, Asia-Pacific Journal of Clinical Oncology	2012	23

Page 1